Latest filing published 26 Apr 2022 for Gemina Laboratories Ltd., €1,781.
Martin Cronin is a declared insider of Gemina Laboratories Ltd., with filings sourced from SEDI. The record holds 3 filings, for trades running from 12 March 2021 to 21 April 2022.
On the market, this insider has only ever bought: 2 purchases, €6,580 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. 2022 to date brings 2 purchases and no sales.
Most recently, on 26 April 2022, the filings show an open-market purchase worth €1,781 in Gemina Laboratories Ltd. Typically, a trade is published a median of 5 days after it takes place. Until a filing is published, the market cannot know about the trade. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations